Huang K E
Am J Obstet Gynecol. 1986 Oct;155(4):824-8. doi: 10.1016/s0002-9378(86)80030-8.
This study was undertaken in order to evaluate the superiority, if any, of progesterone or clomiphene citrate in treatment of infertile women with luteal phase inadequacy. Eighty-two patients were randomly treated with progesterone or clomiphene citrate. Some patients with failure of progesterone were changed to clomiphene citrate treatment; some patients with failure of clomiphene citrate were changed to progesterone treatment. A life-table analysis was used for evaluation of the results. No statistical difference was noticed between the two treatments. Seventeen of 57 patients treated with progesterone and 13 of 62 patients treated with clomiphene citrate conceived. It is recommended that: patients with luteal phase inadequacy can be treated primarily with progesterone; an endometrial biopsy should be performed if the patients fail to conceive; if endometrial biopsy continues to be abnormal the patients can be treated again with clomiphene citrate. Some alternative treatments for luteal phase inadequacy are needed.
本研究旨在评估黄体酮或枸橼酸氯米芬在治疗黄体期缺陷的不孕女性中是否具有优势。82例患者被随机给予黄体酮或枸橼酸氯米芬治疗。一些黄体酮治疗失败的患者改为枸橼酸氯米芬治疗;一些枸橼酸氯米芬治疗失败的患者改为黄体酮治疗。采用寿命表分析来评估结果。两种治疗方法之间未发现统计学差异。接受黄体酮治疗的57例患者中有17例怀孕,接受枸橼酸氯米芬治疗的62例患者中有13例怀孕。建议:黄体期缺陷的患者可首先用黄体酮治疗;如果患者未能怀孕,应进行子宫内膜活检;如果子宫内膜活检持续异常,患者可再次用枸橼酸氯米芬治疗。黄体期缺陷需要一些替代治疗方法。